{"count":220403,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1294","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1292","results":[{"created":"2021-06-16T11:32:19.194164+10:00","panel_name":"Amelogenesis imperfecta","panel_id":3564,"panel_version":"0.1","user_name":"Belinda Chong","item_type":"entity","text":"reviewed gene: AMBN: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 24858907, 26502894; Phenotypes: Amelogenesis imperfecta, type IF MIM#616270; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"AMBN","entity_type":"gene"},{"created":"2021-06-16T11:04:06.215052+10:00","panel_name":"Amelogenesis imperfecta","panel_id":3564,"panel_version":"0.1","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: GPR68: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 27693231, 32279993; Phenotypes: Amelogenesis imperfecta, hypomaturation type, IIA6 MIM#617217; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GPR68","entity_type":"gene"},{"created":"2021-06-16T10:59:38.415109+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1117","user_name":"Teresa Zhao","item_type":"entity","text":"reviewed gene: SLC13A5: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 24995870, 26384929; Phenotypes: Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta MIM#615905; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"SLC13A5","entity_type":"gene"},{"created":"2021-06-16T10:59:32.245963+10:00","panel_name":"Amelogenesis imperfecta","panel_id":3564,"panel_version":"0.1","user_name":"Teresa Zhao","item_type":"entity","text":"reviewed gene: SLC13A5: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 24995870, 26384929; Phenotypes: Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta MIM#615905; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"SLC13A5","entity_type":"gene"},{"created":"2021-06-16T10:56:50.863048+10:00","panel_name":"Amelogenesis imperfecta","panel_id":3564,"panel_version":"0.1","user_name":"Naomi Baker","item_type":"entity","text":"reviewed gene: ROGDI: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 22424600, 29153277, 25565929; Phenotypes: Kohlschutter-Tonz syndrome MIM #226750; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ROGDI","entity_type":"gene"},{"created":"2021-06-16T10:52:33.987613+10:00","panel_name":"Amelogenesis imperfecta","panel_id":3564,"panel_version":"0.1","user_name":"Belinda Chong","item_type":"entity","text":"edited their review of gene: ACP4: Changed rating: GREEN","entity_name":"ACP4","entity_type":"gene"},{"created":"2021-06-16T10:46:03.746446+10:00","panel_name":"Amelogenesis imperfecta","panel_id":3564,"panel_version":"0.1","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: FAM83H: Rating: GREEN; Mode of pathogenicity: Other; Publications: PMID: 19407157; Phenotypes: Amelogenesis imperfecta, type IIIA MIM#130900; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","entity_name":"FAM83H","entity_type":"gene"},{"created":"2021-06-16T10:43:46.356676+10:00","panel_name":"Amelogenesis imperfecta","panel_id":3564,"panel_version":"0.1","user_name":"Belinda Chong","item_type":"entity","text":"reviewed gene: ACP4: Rating: ; Mode of pathogenicity: None; Publications: PMID: 27843125, 33552707; Phenotypes: Amelogenesis imperfecta, type IJ MIM#617297; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ACP4","entity_type":"gene"},{"created":"2021-06-16T10:40:15.892526+10:00","panel_name":"Amelogenesis imperfecta","panel_id":3564,"panel_version":"0.1","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: FAM20C: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 17924334, 25928877, 24026952; Phenotypes: Raine syndrome MIM#259775; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FAM20C","entity_type":"gene"},{"created":"2021-06-16T10:32:54.856569+10:00","panel_name":"Amelogenesis imperfecta","panel_id":3564,"panel_version":"0.1","user_name":"Teresa Zhao","item_type":"entity","text":"reviewed gene: SLC10A7: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 30082715; Phenotypes: Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis (MIM#618363); Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"SLC10A7","entity_type":"gene"},{"created":"2021-06-16T10:17:56.805621+10:00","panel_name":"Amelogenesis imperfecta","panel_id":3564,"panel_version":"0.1","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: FAM20A: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 21990045; Phenotypes: Amelogenesis imperfecta, type IG (enamel-renal syndrome) MIM#204690; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FAM20A","entity_type":"gene"},{"created":"2021-06-16T08:26:39.061710+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.268","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GATA2 as ready","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:26:39.049538+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.268","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gata2 has been classified as Green List (High Evidence).","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:26:14.197871+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8037","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GATA2 as ready","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:26:14.188269+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8037","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gata2 has been classified as Green List (High Evidence).","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:24:41.847501+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8037","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GATA2 were changed from  to Immunodeficiency 21, MIM# 614172; GATA2 deficiency with susceptibility to MDS/AML MONDO:0042982; Emberger syndrome, MIM# 614038; Deafness-lymphoedema-leukaemia syndrome MONDO:0013540","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:24:16.253767+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8036","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GATA2 were set to ","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:23:51.860321+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8035","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GATA2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:23:30.213643+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8034","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GATA2: Rating: GREEN; Mode of pathogenicity: None; Publications: 21670465, 21242295, 21892158; Phenotypes: Immunodeficiency 21, MIM# 614172, GATA2 deficiency with susceptibility to MDS/AML MONDO:0042982, Emberger syndrome, MIM# 614038, Deafness-lymphoedema-leukaemia syndrome MONDO:0013540; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:23:16.186768+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.268","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GATA2 were changed from  to Immunodeficiency 21, MIM# 614172; GATA2 deficiency with susceptibility to MDS/AML MONDO:0042982; Emberger syndrome, MIM# 614038; Deafness-lymphoedema-leukaemia syndrome MONDO:0013540","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:20:02.731069+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.267","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GATA2 were set to ","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:19:33.198783+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.266","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GATA2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:19:01.240813+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.265","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: GATA2: Changed phenotypes: Immunodeficiency 21, MIM# 614172, MONDO:0042982, Emberger syndrome, MIM# 614038, MONDO:0013540","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:18:01.273192+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.265","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: This primary immunodeficiency, designated IMD21, DCML, or MONOMAC, is characterized by profoundly decreased or absent monocytes, B lymphocytes, natural killer (NK) lymphocytes, and circulating and tissue dendritic cells (DCs), with little or no effect on T-cell numbers. Clinical features of IMD21 are variable and include susceptibility to disseminated nontuberculous mycobacterial infections, papillomavirus infections, opportunistic fungal infections, and pulmonary alveolar proteinosis.\r\n\r\nBone marrow hypocellularity and dysplasia of myeloid, erythroid, and megakaryocytic lineages are present in most individuals, as are karyotypic abnormalities, including monosomy 7 and trisomy 8. In the absence of cytogenetic abnormalities or overt dysplasia, hypoplastic bone marrow may initially be diagnosed as aplastic anaemia.\r\n\r\nLess common manifestations of GATA2 deficiency include lymphedema and sensorineural hearing loss, a phenotype usually termed 'Emberger syndrome'.\r\n\r\nOver 20 unrelated individuals reported.; to: This primary immunodeficiency, designated IMD21, DCML, or MONOMAC, is characterized by profoundly decreased or absent monocytes, B lymphocytes, natural killer (NK) lymphocytes, and circulating and tissue dendritic cells (DCs), with little or no effect on T-cell numbers. Clinical features of IMD21 are variable and include susceptibility to disseminated nontuberculous mycobacterial infections, papillomavirus infections, opportunistic fungal infections, and pulmonary alveolar proteinosis.\r\n\r\nBone marrow hypocellularity and dysplasia of myeloid, erythroid, and megakaryocytic lineages are present in most individuals, as are karyotypic abnormalities, including monosomy 7 and trisomy 8. In the absence of cytogenetic abnormalities or overt dysplasia, hypoplastic bone marrow may initially be diagnosed as aplastic anaemia.\r\n\r\nLess common manifestations of GATA2 deficiency include lymphoedema and sensorineural hearing loss, a phenotype usually termed 'Emberger syndrome'.\r\n\r\nOver 20 unrelated individuals reported.","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:17:51.579329+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.265","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GATA2: Rating: GREEN; Mode of pathogenicity: None; Publications: 21670465, 21242295, 21892158; Phenotypes: Immunodeficiency 21, MIM# 614172; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GATA2","entity_type":"gene"},{"created":"2021-06-16T08:07:07.209746+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8034","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GATA1 as ready","entity_name":"GATA1","entity_type":"gene"},{"created":"2021-06-16T08:07:07.200673+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8034","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gata1 has been classified as Green List (High Evidence).","entity_name":"GATA1","entity_type":"gene"},{"created":"2021-06-16T08:06:56.907625+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8034","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GATA1 were changed from  to Thrombocytopaenia, X-linked, with or without dyserythropoietic anaemia, MIM# 300367","entity_name":"GATA1","entity_type":"gene"},{"created":"2021-06-16T08:06:33.965557+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8033","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GATA1 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"GATA1","entity_type":"gene"},{"created":"2021-06-16T08:06:11.281823+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8032","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GATA1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Thrombocytopaenia, X-linked, with or without dyserythropoietic anaemia, MIM# 300367; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"GATA1","entity_type":"gene"},{"created":"2021-06-16T08:05:23.451671+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.265","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GATA1 as ready","entity_name":"GATA1","entity_type":"gene"},{"created":"2021-06-16T08:05:23.435797+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.265","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gata1 has been classified as Green List (High Evidence).","entity_name":"GATA1","entity_type":"gene"},{"created":"2021-06-16T08:05:20.265276+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.265","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GATA1 were changed from  to Thrombocytopaenia, X-linked, with or without dyserythropoietic anaemia, MIM# 300367","entity_name":"GATA1","entity_type":"gene"},{"created":"2021-06-16T08:04:47.068582+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.264","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GATA1 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"GATA1","entity_type":"gene"},{"created":"2021-06-16T08:03:25.222426+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.55","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: G6PC3 as ready","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T08:03:25.212361+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.55","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: g6pc3 has been classified as Green List (High Evidence).","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T08:03:21.945605+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.55","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: G6PC3 were changed from  to Neutropaenia, severe congenital 4, autosomal recessive, MIM# 612541; MONDO:0012930; Dursun syndrome, MIM# 612541","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T08:02:50.543554+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.54","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: G6PC3 were set to ","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T08:02:15.150905+10:00","panel_name":"Pulmonary Arterial Hypertension","panel_id":3095,"panel_version":"1.7","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: G6PC3 as ready","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T08:02:15.140342+10:00","panel_name":"Pulmonary Arterial Hypertension","panel_id":3095,"panel_version":"1.7","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: g6pc3 has been classified as Green List (High Evidence).","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T08:02:01.593012+10:00","panel_name":"Pulmonary Arterial Hypertension","panel_id":3095,"panel_version":"1.7","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: G6PC3 as Green List (high evidence)","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T08:02:01.582029+10:00","panel_name":"Pulmonary Arterial Hypertension","panel_id":3095,"panel_version":"1.7","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: g6pc3 has been classified as Green List (High Evidence).","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T08:01:52.918115+10:00","panel_name":"Pulmonary Arterial Hypertension","panel_id":3095,"panel_version":"1.6","user_name":"Zornitza Stark","item_type":"entity","text":"gene: G6PC3 was added\ngene: G6PC3 was added to Pulmonary Arterial Hypertension. Sources: Expert Review\nMode of inheritance for gene: G6PC3 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: G6PC3 were set to 19118303; 20799326; 25492228; 17318259; 20616219\nPhenotypes for gene: G6PC3 were set to Neutropaenia, severe congenital 4, autosomal recessive, MIM# 612541; MONDO:0012930; Dursun syndrome, MIM# 612541\nReview for gene: G6PC3 was set to GREEN\nAdded comment: Over 20 unrelated families reported, mouse models. Dursun syndrome describes a subset of patients with pulmonary hypertension. \nSources: Expert Review","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T08:00:52.823047+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: G6PC3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T08:00:27.032020+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.52","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: G6PC3: Rating: GREEN; Mode of pathogenicity: None; Publications: 19118303, 20799326, 25492228, 17318259, 20616219; Phenotypes: Neutropenia, severe congenital 4, autosomal recessive, MIM# 612541, MONDO:0012930, Dursun syndrome, MIM# 612541; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T07:59:37.789734+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.263","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: G6PC3: Changed phenotypes: Neutropaenia, severe congenital 4, autosomal recessive, MIM# 612541, MONDO:0012930, Dursun syndrome, MIM# 612541","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T07:59:27.749261+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.263","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: G6PC3 as ready","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T07:59:27.738941+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.263","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: g6pc3 has been classified as Green List (High Evidence).","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T07:59:14.893017+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.263","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: G6PC3 were changed from  to Neutropaenia, severe congenital 4, autosomal recessive, MIM# 612541; MONDO:0012930; Dursun syndrome, MIM# 612541","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T07:58:41.877475+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.262","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: G6PC3 were set to ","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T07:58:10.757056+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.261","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: G6PC3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-16T07:57:38.639347+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.260","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: G6PC3: Rating: GREEN; Mode of pathogenicity: None; Publications: 19118303, 20799326, 25492228, 17318259, 20616219; Phenotypes: Neutropenia, severe congenital 4, autosomal recessive, MIM# 612541, MONDO:0012930, Dursun syndrome, MIM# 612541; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"G6PC3","entity_type":"gene"},{"created":"2021-06-15T21:34:07.148431+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.260","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCG as ready","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-06-15T21:34:07.130685+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.260","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fancg has been classified as Green List (High Evidence).","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-06-15T21:34:04.922598+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.260","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCG were changed from  to Fanconi anaemia, complementation group G, MIM# 614082; MONDO:0013565","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-06-15T21:33:47.671957+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.259","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCG were set to ","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-06-15T21:33:14.957396+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.258","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCG was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-06-15T21:32:16.039943+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.257","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCF as ready","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-06-15T21:32:16.029888+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.257","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fancf has been classified as Green List (High Evidence).","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-06-15T21:32:12.793892+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.257","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCF were changed from  to Fanconi anaemia, complementation group F 603467; MONDO:0011325","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-06-15T21:31:43.908380+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.256","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCF were set to ","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-06-15T21:31:14.353254+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.255","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCF was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-06-15T21:17:52.177940+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.252","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCB as ready","entity_name":"FANCB","entity_type":"gene"},{"created":"2021-06-15T21:17:52.166482+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.252","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fancb has been classified as Green List (High Evidence).","entity_name":"FANCB","entity_type":"gene"},{"created":"2021-06-15T21:17:42.967854+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.252","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCB were changed from  to Fanconi anaemia, complementation group B, MIM# 300514","entity_name":"FANCB","entity_type":"gene"},{"created":"2021-06-15T21:17:21.547915+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.251","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCB were set to ","entity_name":"FANCB","entity_type":"gene"},{"created":"2021-06-15T21:16:49.970754+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.250","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCB was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"FANCB","entity_type":"gene"},{"created":"2021-06-15T21:16:24.964692+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCB: Rating: GREEN; Mode of pathogenicity: None; Publications: 15502827; Phenotypes: Fanconi anaemia, complementation group B, MIM# 300514; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"FANCB","entity_type":"gene"},{"created":"2021-06-15T21:15:14.266454+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8032","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ELANE as ready","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:15:14.254229+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8032","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: elane has been classified as Green List (High Evidence).","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:15:07.076911+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8032","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ELANE were changed from  to Neutropaenia, severe congenital 1, autosomal dominant, MIM# 202700","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:14:48.177994+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8031","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ELANE were set to ","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:14:28.026991+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8030","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ELANE was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:14:07.869804+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8029","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ELANE: Rating: GREEN; Mode of pathogenicity: None; Publications: 19036076; Phenotypes: Neutropaenia, severe congenital 1, autosomal dominant, MIM# 202700; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:13:42.531088+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ELANE as ready","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:13:42.520766+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: elane has been classified as Green List (High Evidence).","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:13:39.615963+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ELANE were changed from  to Neutropaenia, severe congenital 1, autosomal dominant, MIM# 202700","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:13:14.114919+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.248","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ELANE were set to ","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:12:46.826928+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.247","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ELANE was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:12:14.996976+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: ELANE: Changed publications: 19036076","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:11:41.940832+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ELANE: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Neutropaenia, severe congenital 1, autosomal dominant, MIM# 202700; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ELANE","entity_type":"gene"},{"created":"2021-06-15T21:10:03.000288+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CTC1 as ready","entity_name":"CTC1","entity_type":"gene"},{"created":"2021-06-15T21:10:02.987854+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ctc1 has been classified as Green List (High Evidence).","entity_name":"CTC1","entity_type":"gene"},{"created":"2021-06-15T21:02:17.233948+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8029","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EFL1 as ready","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T21:02:17.223421+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8029","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: efl1 has been classified as Green List (High Evidence).","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T21:02:08.404566+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8029","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: EFL1 were changed from  to Shwachman-Diamond syndrome 2, MIM# 617941","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T21:01:50.106837+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8028","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: EFL1 were set to ","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T21:01:30.744185+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8027","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: EFL1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T21:00:58.101573+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8026","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: EFL1: Rating: GREEN; Mode of pathogenicity: None; Publications: 28331068, 31151987; Phenotypes: Shwachman-Diamond syndrome 2, MIM# 617941; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T21:00:24.314315+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EFL1 as ready","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T21:00:24.304448+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: efl1 has been classified as Green List (High Evidence).","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T21:00:21.084533+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: EFL1 were changed from  to Shwachman-Diamond syndrome 2, MIM# 617941","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T20:59:43.572942+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.245","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: EFL1 were set to ","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T20:59:21.478468+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.244","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: EFL1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T20:58:58.281315+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.243","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: EFL1: Rating: GREEN; Mode of pathogenicity: None; Publications: 28331068, 31151987; Phenotypes: Shwachman-Diamond syndrome 2, MIM# 617941; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"EFL1","entity_type":"gene"},{"created":"2021-06-15T20:57:23.240512+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8026","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CXCR4 as ready","entity_name":"CXCR4","entity_type":"gene"},{"created":"2021-06-15T20:57:23.230975+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8026","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cxcr4 has been classified as Green List (High Evidence).","entity_name":"CXCR4","entity_type":"gene"},{"created":"2021-06-15T20:57:13.111205+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8026","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CXCR4 were changed from  to WHIM syndrome, MIM# 193670","entity_name":"CXCR4","entity_type":"gene"},{"created":"2021-06-15T20:56:55.860811+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8025","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CXCR4 were set to ","entity_name":"CXCR4","entity_type":"gene"},{"created":"2021-06-15T20:56:37.873726+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.8024","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CXCR4 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CXCR4","entity_type":"gene"}]}